Fidelity International’s Sinovac Biotech, Ltd SVA Stock Holding History

Fidelity International’s Portfolio SVA Stock Details SVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-1,091,500	Closed	-$6.24M	–	541
2015 Q4	$6.24M	Hold	1,091,500	–	–	0.02%	364
2015 Q3	$5.54M	Hold	1,091,500	–	–	0.02%	376
2015 Q2	$5.73M	Hold	1,091,500	–	–	0.02%	405
2015 Q1	$5.41M	Buy	1,091,500 +26,199	+2%	+$129K	0.02%	410
2014 Q4	$5.57M	Buy	1,065,301 +116,001	+12%	+$591K	0.02%	393
2014 Q3	$4.57M	Hold	949,300	–	–	0.02%	407
2014 Q2	$5.35M	Sell	949,300 -120,200	-11%	-$730K	0.02%	399
2014 Q1	$7.7M	Hold	1,069,500	–	–	0.03%	362
2013 Q4	$6.54M	Hold	1,069,500	–	–	0.03%	365
2013 Q3	$6.4M	Hold	1,069,500	–	–	0.03%	354
2013 Q2	$4.2M	Buy	+1,069,500	New	+$3.98M	0.02%	356

Other funds holding SVA

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

USAA

United Services Automobile Association San Antonio, Texas $1.24B AUM 2.91% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

FIM

Freedom Investment Management Hartford, Connecticut $359M AUM 23.01% 1-Year Est. Return

PRCM

Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity International's SVA Position: Q1 2016 in Review

Fidelity International sold out of Sinovac Biotech, Ltd (SVA) in Q1 2016, closing a stake of 1,091,500 shares — an estimated $6.24M sold.

Fidelity International first reported a position in SVA in Q2 2013 and held it in 11 quarters. The position peaked at $7.7M in Q1 2014. 34 funds tracked by Wall St. Rank hold SVA as of Q1 2016.

Fidelity International reported no remaining Sinovac Biotech, Ltd position as of Q1 2016 after selling out during the quarter.
Fidelity International sold 1,091,500 Sinovac Biotech, Ltd shares in Q1 2016, an estimated $6.24M.
Fidelity International first reported a position in Sinovac Biotech, Ltd in Q2 2013 and held it in 11 quarters.
Fidelity International's Sinovac Biotech, Ltd position peaked at $7.7M in Q1 2014.
34 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q1 2016.

Based on Fidelity International's 13F filing for Q1 2016, filed 16 May 2016.